Integrated Filing — IndAS



General information about company

Scrip Code 543336
NSE Symbol CHEMPLASTS
MSEI Symbol NOTLISTED
ISIN INE488A01050
Name of company CHEMPLAST SANMAR LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 25-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 19-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Speciality Chemicals
Start date and time of board meeting 25-05-2026   17:45:00
End date and time of board meeting 25-05-2026   18:50:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 07-02-2026
Indicate Company website link for updated RPT policy of the Company https://www.chemplastsanmar.com/downloads/investor-relations/csl-policies/Related-Party-Transactions-Policy-2026-Version-V.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 61,224.00 2,16,998.00
Other income 384.00 1,457.00
Total income 61,608.00 2,18,455.00
2 Expenses
(a) Cost of materials consumed 19,175.00 89,508.00
(b) Purchases of stock-in-trade 1,779.00 12,747.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 6,803.00 2,264.00
(d) Employee benefit expense 4,739.00 17,908.00
(e) Finance costs 2,681.00 10,691.00
(f) Depreciation, depletion and amortisation expense 4,013.00 15,638.00
(f) Other Expenses
1 Power and fuel 12,923.00 52,797.00
2 Stores consumed 920.00 3,762.00
3 Repairs and maintenance 1,821.00 6,956.00
4 Freight and handling 1,221.00 4,094.00
5 Insurance 324.00 1,312.00
6 Outside processing expenses 156.00 1,235.00
7 Difference in foreign exchange (net) 219.00 1,427.00
8 Rates and taxes 339.00 881.00
9 Legal and Professional fees 787.00 3,126.00
10 Miscellaneous expenses 1,763.00 8,164.00
Total other expenses 20,473.00 83,754.00
Total expenses 59,663.00 2,32,510.00
3 Total profit before exceptional items and tax 1,945.00 (14,055.00)
4 Exceptional items (89,800.00) (89,800.00)
5 Total profit before tax (87,855.00) (1,03,855.00)
6 Tax expense
7 Current tax 0.00 0.00
8 Deferred tax 439.00 (3,516.00)
9 Total tax expenses 439.00 (3,516.00)
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations (88,294.00) (1,00,339.00)
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period (88,294.00) (1,00,339.00)
17 Other comprehensive income net of taxes 76.00 18.00
18 Total Comprehensive Income for the period (88,218.00) (1,00,321.00)
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 7,906.00 7,906.00
Face value of equity share capital 5 5
27 Details of debt securities
22 Reserves excluding revaluation reserve 1,69,780.00
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations -55.84 -63.46
Diluted earnings (loss) per share from continuing operations -55.84 -63.46
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -55.84 -63.46
Diluted earnings (loss) per share from continuing and discontinued operations -55.84 -63.46
24 Debt equity ratio 37.00 37.00
25 Debt service coverage ratio 170.9100 63.3500
26 Interest service coverage ratio 172.0300 -32.4700
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. In terms of Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements 2015, this Statement of Audited Standalone Financial Results for the quarter and year ended 31st March 2026 Audited Standalone Financial Results of Chemplast Sanmar Limited the Company has been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on 25th May 2026. The statutory auditors have expressed an unmodified opinion on the Audited Standalone Financial Results. The figures for the quarter ended 31st March, 2026 and 31st March, 2025 are the balancing figures between audited figures in respect of the full financial year and year to date figure up to the third quarter of the relevant financial year which were subject to limited review. 2. The Audited Standalone Financial Results of the Company have been prepared in accordance with Indian Accounting Standards Ind AS notified under Section 133 of the Companies Act, 2013 read with the Companies Indian Accounting Standards Rules, 2015 as amended and in terms of Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015 Listing Requirements. 3. The Companys operations predominantly relate to manufacture and sale of Speciality Chemicals. As the Company's business activity falls within a single business segment viz Speciality Chemicals and the sales substantially being in the domestic market, and as such there is no other separate reportable segment as per Ind AS 108 Operating Segments. The Company has disclosed the segment information in the consolidated financial results. 4. During the year 2024-25, the Company has elected to exercise the option permitted under section 115BAA of the Income Tax Act, 1961 with effect from FY 2023-24. Accordingly, the Deferred Tax Liability net as of March 31, 2024, along with the tax expense for 2024-25, was remeasured at a lower tax rate. Furthermore, following the amendment in tax rates affecting certain assets with long-term capital gains, as introduced in the Finance Act, 2024, the Company reassessed its deferred tax liabilities related to the revaluation of land. The cumulative impact of these adjustments resulted in the reversal of deferred tax liability, which is recognized in the Statement of Profit and Loss and other comprehensive income, amounting to Rs 18.41 crores and Rs 135.09 crores respectively for the year ended 31st March 2025. 5. For the year ended 31st March 2025, the Company conducted a periodic valuation of select property, plant, and equipment through independent valuers, in accordance with its accounting policy. As a result, a revaluation gain of Rs 351.66 crores and the consequential deferred tax liability of Rs 64.37 crores was recognized under other comprehensive income in the standalone financial results for the year ended 31st March 2025. 6. On 21st November 2025, the Government of India notified the four Labour Codes - the Code on wages 2019, the Industrial Relations Code 2020, the Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020 - 29 existing labour laws, collectively referred to as the New Labour Codes. For the year ended March 31, 2026, the Company has assessed and recorded the incremental impact of these changes amounting to Rs 3.49 Crores, determined taking into consideration the best information available read with the FAQs released by Ministry of Labour and Employment and Institute of Chartered Accountants of India. The Company continues to monitor developments on the rules to be notified by regulatory authorities, including clarifications or additional guidance from authorities and will continue to assess the accounting implications basis such developments or guidance. 7. The Companys wholly owned subsidiary - CCVL is engaged in the production and sale of Suspension PVC S-PVC. Pursuant to significant regulatory and market developments in last few months and including non notification of and consequent dropping of the expected anti-dumping duty on S-PVC, removal of customs duty on import of S-PVC, significant reduction in S-PVC prices on account of low priced imports, raw material price volatility due to West-Asia crisis, the Company has revised its budgets or cash flow projections and has done a detailed evaluation of the carrying value of its investment in CCVL as at 31 March 2026 with the help of an independent valuer. Based on such evaluation, the Company has recorded an impairment provision of Rs. 898 Crores as an exceptional item for the quarter and year ended 31 March 2026. 8. This Financial Results is also available on the stock exchange websites www.bseindia.com and www.nseindia.com and on our website www.chemplastsanmar.com.



Remarks

Debt equity ratio
Debt service coverage ratio Increase in ratio due to increase in earnings for debt service
Interest service coverage ratio Increase in ratio is due to increase in earnings for interest service


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 3,40,583.00
Capital work-in-progress 33,562.00
Investment property 0.00
Goodwill 0.00
Other intangible assets 412.00
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 65,768.00
Trade receivables, non-current 0.00
Loans, non-current 0.00
Other non-current financial assets
1 Investement 539.00
2 Other financial assets 3,216.00
Total of other non-current financial assets 3,755.00
Total non-current financial assets 69,523.00
Deferred tax assets (net) 721.00
Other non-current assets
1 Other non-current assets 3,970.00
Total of other non-current assets 3,970.00
Total non-current assets 4,48,771.00
2 Current assets
Inventories 39,140.00
Current financial asset
Current investments 0.00
Trade receivables, current 16,980.00
Cash and cash equivalents 27,586.00
Bank balance other than cash and cash equivalents 3,288.00
Loans, current 3,434.00
Other current financial assets
Total of other current financial assets 5,075.00
Total current financial assets 56,363.00
Current tax assets (net) 0.00
Other current assets
1 Other current assets 13,584.00
Total of other current assets 13,584.00
Total current assets 1,09,087.00
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 5,57,858.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 7,906.00
Other equity 3,11,441.00
Total equity attributable to owners of parent 3,19,347.00
Non controlling interest
Total equity 3,19,347.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 68,838.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Other financial liabilities 3,750.00
Total of other non-current financial liabilities 3,750.00
Total non-current financial liabilities 72,588.00
Provisions, non-current 0.00
Deferred tax liabilities (net) 31,744.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
1 Other non-current liabilities 1,047.00
Total of other non-current liabilities 1,047.00
Total non-current liabilities 1,05,379.00
Current liabilities
Current financial liabilities
Borrowings, current 49,150.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 787.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 58,137.00
Total Trade payable 58,924.00
Other current financial liabilities
1 Other financial liabilities 16,561.00
Total of other current financial liabilities 16,561.00
Total current financial liabilities 1,24,635.00
Other current liabilities 6,766.00
1 Other current liabilities 6,222.00
2 Provisions 544.00
Total of other current liabilities 6,766.00
Provisions, current 0.00
Current tax liabilities (Net) 1,731.00
Deferred government grants, Current 0.00
Total current liabilities 1,33,132.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 2,38,511.00
Total equity and liabilites 5,57,858.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss (102.00) (24.00)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 26.00 6.00
5 Total Other comprehensive income 76.00 18.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax (1,03,855.00)
Adjustments for reconcile profit (loss)
Adjustments for finance costs 10,691.00
Adjustments for decrease (increase) in inventories 436.00
Adjustments for decrease (increase) in trade receivables, current 3,095.00
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (2,257.00)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 15,638.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current (11.00)
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 3,758.00
Adjustments for dividend income 0.00
Adjustments for interest income 1,286.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) (3,970.00)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (5.00)
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 89,800.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 1,15,889.00
Net cash flows from (used in) operations 12,034.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 75.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 11,959.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 535.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 14.00
Purchase of property, plant and equipment 30,822.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 3,434.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 1,238.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 1,638.00
Net cash flows from (used in) investing activities (31,901.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 1,58,366.00
Repayments of borrowings 1,40,802.00
Payments of lease liabilities 114.00
Dividends paid 0.00
Interest paid 10,361.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 7,089.00
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (12,853.00)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (12,853.00)
Cash and cash equivalents cash flow statement at beginning of period 40,439.00
Cash and cash equivalents cash flow statement at end of period 27,586.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 B S R & Co. LLP Yes 31-07-2028


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Chemplast Sanmar Limited Chemplast Cuddalore Vinlys Ltd (CCVL) Subsidiary Sale of goods or services 90,000.00 Approved 13,218.00 (1,105.00) 7,031.00
2 Chemplast Sanmar Limited Chemplast Cuddalore Vinlys Ltd (CCVL) Subsidiary Purchase of goods or services 26,982.00 Approved 7,565.00 (1,105.00) 7,031.00
3 Chemplast Sanmar Limited Chemplast Cuddalore Vinlys Ltd (CCVL) Subsidiary Any other transaction Rent Paid 18.00 Approved 18.00 (1,105.00) 7,031.00
4 Chemplast Sanmar Limited Chemplast Cuddalore Vinlys Ltd (CCVL) Subsidiary Any other transaction Reimbursement received 574.00 Approved 574.00 (1,105.00) 7,031.00
5 Chemplast Sanmar Limited Chemplast Cuddalore Vinlys Ltd (CCVL) Subsidiary Any other transaction Reimbursement paid 2,426.00 Approved 1,875.00 (1,105.00) 7,031.00
6 Chemplast Sanmar Limited TCI Sanmar Chemicals S.A.E. Fellow Subisdary Any other transaction Reimbursement received 750.00 Approved 359.00 0.00 0.00
7 Chemplast Sanmar Limited Chemplast Cuddalore Vinlys Ltd (CCVL) Subsidiary Inter-corporate deposit 4,000.00 Approved 3,432.00 0.00 3,434.00
8 Chemplast Sanmar Limited Chemplast Cuddalore Vinlys Ltd (CCVL) Subsidiary Interest received 2.00 Approved 2.00 0.00 3,434.00
Total value of transaction during the reporting period 27,043.00